Steinberg Global Asset Management historic quarter change: Foreign Stocks, Added
In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 13 quarters from 2013-06-30 to 2016-09-30, Steinberg Global Asset Management opened 10 positions, added to 22, reduced 29 and sold out of 14.
- Q1 2016: Stock TEVA; Country of operation —; Class ADR; Shares before 17,216.
- Q4 2015: Stock MUFG; Country of operation —; Class SPONSORED ADR; Shares before 124,885.
- Q4 2015: Stock BP; Country of operation —; Class SPONSORED ADR; Shares before 10,537.
- Q3 2015: Stock MUFG; Country of operation —; Class SPONSORED ADR; Shares before 121,309.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1288917), 13 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-14); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-15); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-16); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-16); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-16); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-08-14); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-08-14); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-17); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-14); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-08-14); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-15); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-01-10); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-10-10). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2004-03-31.
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q1 2016 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 17,216 | 28,555 | +11,339 | $1,130,000 | $1,528,000 | +$398,000 | 2016-05-16 |
|---|
| Q4 2015 | MUFG
MITSUBISHI UFJ FINL GROUP IN | | SPONSORED ADR | 124,885 | 128,252 | +3,367 | $760,000 | $798,000 | +$38,000 | 2016-02-16 |
|---|
| Q4 2015 | BP
BP PLC | | SPONSORED ADR | 10,537 | 10,540 | +3 | $322,000 | $329,000 | +$7,000 | 2016-02-16 |
|---|
| Q3 2015 | MUFG
MITSUBISHI UFJ FINL GROUP IN | | SPONSORED ADR | 121,309 | 124,885 | +3,576 | $876,000 | $760,000 | -$116,000 | 2015-11-16 |
|---|
| Q3 2015 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 16,655 | 17,404 | +749 | $984,000 | $982,000 | -$2,000 | 2015-11-16 |
|---|
| Q2 2015 | NVS
NOVARTIS A G | | SPONSORED ADR | 14,147 | 14,557 | +410 | $1,395,000 | $1,432,000 | +$37,000 | 2015-08-14 |
|---|
| Q2 2015 | BP
BP PLC | | SPONSORED ADR | 10,350 | 10,754 | +404 | $405,000 | $430,000 | +$25,000 | 2015-08-14 |
|---|
| Q1 2015 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 15,681 | 22,457 | +6,776 | $902,000 | $1,400,000 | +$498,000 | 2015-08-14 |
|---|
| Q4 2014 | NVS
NOVARTIS A G | | SPONSORED ADR | 12,793 | 16,887 | +4,094 | $1,204,000 | $1,565,000 | +$361,000 | 2015-02-17 |
|---|
| Q4 2014 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 15,269 | 15,681 | +412 | $820,000 | $902,000 | +$82,000 | 2015-02-17 |
|---|
| Q4 2014 | BP
BP PLC | | SPONSORED ADR | 10,340 | 11,345 | +1,005 | $454,000 | $432,000 | -$22,000 | 2015-02-17 |
|---|
| Q3 2014 | NVS
NOVARTIS A G | | SPONSORED ADR | 12,093 | 12,793 | +700 | $1,095,000 | $1,204,000 | +$109,000 | 2014-11-14 |
|---|
| Q3 2014 | BP
BP PLC | | SPONSORED ADR | 10,336 | 10,340 | +4 | $545,000 | $454,000 | -$91,000 | 2014-11-14 |
|---|
| Q3 2014 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 15,018 | 15,269 | +251 | $787,000 | $820,000 | +$33,000 | 2014-11-14 |
|---|
| Q2 2014 | NVS
NOVARTIS A G | | SPONSORED ADR | 11,448 | 12,093 | +645 | $973,000 | $1,095,000 | +$122,000 | 2014-08-14 |
|---|
| Q2 2014 | TEVA
TEVA PHARMACEUTICAL INDS LTD | | ADR | 14,464 | 15,018 | +554 | $764,000 | $787,000 | +$23,000 | 2014-08-14 |
|---|
| Q4 2013 | NVS
Novartis ADR | | COM | 87,000 | 87,100 | +100 | $6,674,000 | $7,001,000 | +$327,000 | 2014-01-10 |
|---|
| Q4 2013 | FRFHF
Fairfax Financial Holdings Ltd | Canada | COM | 7,337 | 7,364 | +27 | $2,967,000 | $2,940,000 | -$27,000 | 2014-01-10 |
|---|
| Q3 2013 | NVS
Novartis ADR | | COM | 66,950 | 87,000 | +20,050 | $4,734,000 | $6,674,000 | +$1,940,000 | 2013-10-10 |
|---|
| Q3 2013 | FRFHF
Fairfax Financial Holdings Ltd | Canada | COM | 6,904 | 7,337 | +433 | $2,715,000 | $2,967,000 | +$252,000 | 2013-10-10 |
|---|
| Q3 2013 | BP
BP PLC ADR | | COM | 11,821 | 12,025 | +204 | $493,000 | $505,000 | +$12,000 | 2013-10-10 |
|---|
| Q3 2013 | TEVA
Teva Pharm Inds Ltd ADRF 1 | | COM | 21,601 | 22,651 | +1,050 | $847,000 | $856,000 | +$9,000 | 2013-10-10 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |